CJ
PFE icon

Caitlin John’s Pfizer PFE Stock Holding History

Caitlin John’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,500
Closed -$119K – 601
2024
Q4 		$119K Sell
4,500
-2,000
-31% -$54.3K 0.08% 162
2024
Q3 		$174K Sell
6,500
-900
-12% -$26.3K 0.11% 137
2024
Q2 		$207K Buy
+7,400
New +$204K 0.15% 120

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Caitlin John's PFE Position: Q1 2026 in Review

Caitlin John increased its Pfizer (PFE) stake by 5.4% in Q1 2026, buying an estimated $25.2K and bringing the position to 18,482 shares worth $519K. The position accounts for 0.31% of the portfolio, ranked #54.

Caitlin John first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $616K in Q2 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caitlin John held 18,482 shares of Pfizer worth $519K as of Q1 2026.
  • Caitlin John bought 945 Pfizer shares in Q1 2026, an estimated $25.2K.
  • Pfizer made up 0.31% of Caitlin John's portfolio in Q1 2026, its #54 holding.
  • Caitlin John first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Pfizer position peaked at $616K in Q2 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.